Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

NCT03336372 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor discontinued study on 8Sep2018

Conditions

Molluscum Contagiosum

Interventions

DRUG: Picato

Sponsor

Center for Clinical Studies, Texas

Collaborators

[object Object]